|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Nasopharyngeal Neoplasms | |||||
| 2 | More general conditions related to this trial | ||||
| Head and Neck Neoplasms | |||||
| Nasopharyngeal Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Otorhinolaryngologic Diseases | |||||
| Otorhinolaryngologic Neoplasms | |||||
| Pharyngeal Diseases | |||||
| Pharyngeal Neoplasms | |||||
| Stomatognathic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Gemcitabine | |||||
| Oxaliplatin | |||||
| 4 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Antimetabolites | |||||
| Antimetabolites, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Antiviral Agents | |||||
| Enzyme Inhibitors | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Radiation-Sensitizing Agents | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| Sanofi-Aventis | |||||